|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 20 F STREET NW |
Address2 | SUITE 1000 |
City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 91251-12
|
||||||||
|
6. House ID# 363620000
|
TYPE OF REPORT | 8. Year | 2012 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Christian Shalgian, Director, Division of Advocacy and Health Policy |
Date | 01/22/2013 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
See page three for specific Medicare/Medicaid issues.
H.R. 1409 - Quality Health Care Coalition Act of 2011
H. R. 1700 The Medicare Patient Empowerment Act
H.R. 157 - Health Care Safety Net Enhancement Act of 2011
H.R. 2104 - Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011
H.R. 2119 - Ryan Creedon Act of 2011
H.R. 2405 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
H.R. 2600 - National Pediatric Acquired Brain Injury Plan Act of 2011
H.R. 3239 - Safeguarding Access For Every Medicare Patient Act
H.R. 3474 - PRIME Act of 2011
H.R. 3586 - Good Samaritan Health Professionals Act of 2011
H.R. 4310 - National Defense Authorization Act for Fiscal Year 2013
H.R. 451 - Healthcare Truth and Transparency Act of 2011
H.R. 452 - Medicare Decisions Accountability Act of 2011
H.R. 5 - Protecting Access to Healthcare Act
H.R. 5651 - Food and Drug Administration Reform Act of 2012
H.R. 5707 - Medicare Physician Payment Innovation Act of 2012
H.R. 5888 - Physician Reentry Demonstration Program Act
H.R. 5937 Breast Cancer Patient Education Act of 2012
H.R. 5998 - USPSTF Transparency and Accountability Act of 2012
H. R. 6043 - Behavioral Health Information Technology Act of 2012
H.R. 6352 - Resident Physician Shortage Reduction and Graduate Medical Education Accountability & Transparency Act
H. R. 6598 - Electronic Health Records Improvement Act
S. 1099 - Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2011
S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization of 2011
S. 2516 - Food and Drug Administration Safety and Innovation Act
S. 3201 - Graduate Medical Education Reform Act of 2012
Accountable Care Organizations Final Rule
ACS VBU (Value Based-Update) proposal
Ambulatory Surgical Centers
Cancer programs appropriations
Children's Hospitals Graduate Medical Education Payment Program funding
CMS EHR Stage 2 Proposed Rule
CMS RUC Refinement
Electronic Health Record Meaningful Use Stage 2 Issues
Federal Privacy laws
Health Information Technology (45 CFR Part 170)
HHS ASPR/MSET Program
HAI prevention
Imaging
Inspiring Quality Campaign
IPAB
Medical Device User Fee and Modernization Act (MDUFMA)
Medicare audit programs
Medicare fraud identification efforts
Medicare Inpatient Prospective Payment System Proposed Rule
Medicare Liability Reform
Medicare SGR and Overseas Contingency Operations funds
NIH Appropriations
Nominations for the Committee on Governance and Financing of Graduate Medical Education
Nominations for the Medicare Payment Advisory Commission
Pediatric subspecialty loan repayment program
Prescription Drug User Fee Act (PDUFA) reauthorization
(MMM Continued)
Physician Fee Schedule and OPPS/ASC CY 2012 Proposed Rule
Physician Quality Reporting System (PQRS)
Quality and Value Based Purchasing Provisions of Medicare Physician Fee Schedule Final Rule
Risk pool legislation
RUC Refinement panel valuation problem
Rx Drug and Surgical Workforce shortages
Sequestration
Surgical Consumer Assessment of Healthcare Providers and Systems (S-CAHPS)
Trauma Appropriations
Value-Based Update (VBU) Proposal
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Medicare Payment Advisory Commission (MedPAC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christian |
Shalgian |
|
|
|
John |
Hedstrom |
|
|
|
Matt |
Coffron |
|
|
|
Kristin |
McDonald |
|
|
|
Dana |
Halvorson |
|
|
|
Sara |
Morse |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
See page six for specific Health Care Issues.
H.R. 1409 - Quality Health Care Coalition Act of 2011
H. R. 1700 The Medicare Patient Empowerment Act
H.R. 157 - Health Care Safety Net Enhancement Act of 2011
H.R. 2104 - Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011
H.R. 2119 - Ryan Creedon Act of 2011
H.R. 2405 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
H.R. 2600 - National Pediatric Acquired Brain Injury Plan Act of 2011
H.R. 3239 - Safeguarding Access For Every Medicare Patient Act
H.R. 3474 - PRIME Act of 2011
H.R. 3586 - Good Samaritan Health Professionals Act of 2011
H.R. 4310 - National Defense Authorization Act for Fiscal Year 2013
H.R. 451 - Healthcare Truth and Transparency Act of 2011
H.R. 452 - Medicare Decisions Accountability Act of 2011
H.R. 5 - Protecting Access to Healthcare Act
H.R. 5651 - Food and Drug Administration Reform Act of 2012
H.R. 5707 - Medicare Physician Payment Innovation Act of 2012
H.R. 5888 - Physician Reentry Demonstration Program Act
H.R. 5937 Breast Cancer Patient Education Act of 2012
H.R. 5998 - USPSTF Transparency and Accountability Act of 2012
H. R. 6043 - Behavioral Health Information Technology Act of 2012
H.R. 6352 - Resident Physician Shortage Reduction and Graduate Medical Education Accountability & Transparency Act
H. R. 6598 - Electronic Health Records Improvement Act
S. 1099 - Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2011
S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization of 2011
S. 2516 - Food and Drug Administration Safety and Innovation Act
S. 3201 - Graduate Medical Education Reform Act of 2012
Accountable Care Organizations Final Rule
ACS VBU (Value Based-Update) proposal
Ambulatory Surgical Centers
Cancer programs appropriations
Children's Hospitals Graduate Medical Education Payment Program funding
CMS EHR Stage 2 Proposed Rule
CMS RUC Refinement
Electronic Health Record Meaningful Use Stage 2 Issues
Federal Privacy laws
Health Information Technology (45 CFR Part 170)
HHS ASPR/MSET Program
HAI prevention
Imaging
Inspiring Quality Campaign
IPAB
Medical Device User Fee and Modernization Act (MDUFMA)
Medicare audit programs
Medicare fraud identification efforts
Medicare Inpatient Prospective Payment System Proposed Rule
Medicare Liability Reform
Medicare SGR and Overseas Contingency Operations funds
NIH Appropriations
Nominations for the Committee on Governance and Financing of Graduate Medical Education
Nominations for the Medicare Payment Advisory Commission
Pediatric subspecialty loan repayment program
Prescription Drug User Fee Act (PDUFA) reauthorization
(HCR Continued)
Physician Fee Schedule and OPPS/ASC CY 2012 Proposed Rule
Physician Quality Reporting System (PQRS)
Quality and Value Based Purchasing Provisions of Medicare Physician Fee Schedule Final Rule
Risk pool legislation
RUC Refinement panel valuation problem
Rx Drug and Surgical Workforce shortages
Sequestration
Surgical Consumer Assessment of Healthcare Providers and Systems (S-CAHPS)
Trauma Appropriations
Value-Based Update (VBU) Proposal
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Medicare Payment Advisory Commission (MedPAC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christian |
Shalgian |
|
|
|
John |
Hedstrom |
|
|
|
Matt |
Coffron |
|
|
|
Kristin |
McDonald |
|
|
|
Dana |
Halvorson |
|
|
|
Sara |
Morse |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
See page nine for specific Budget/Appropriations issues.
H.R. 2055 - Consolidated Appropriations Act, 2012
House Budget H.Con.Res. 34
FY 2012 Trauma Funding
FY 2012 Cancer Appropriations
NIH Appropriations
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christian |
Shalgian |
|
|
|
John |
Hedstrom |
|
|
|
Matt |
Coffron |
|
|
|
Kristin |
McDonald |
|
|
|
Dana |
Halvorson |
|
|
|
Sara |
Morse |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
5 |
|
||||||
2 |
|
6 |
|
||||||
3 |
|
7 |
|
||||||
4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 3 | 5 |
2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 5 | 9 |
2 | 6 | 10 |
3 | 7 | 11 |
4 | 8 | 12 |